New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

Postural tachycardia syndrome - 33% of POTS patients have organ-specific autoantibodies...

Discussion in 'Other Health News and Research' started by Bob, Nov 11, 2014.

  1. Bob


    England (south coast)
    New autoimmune research on POTS from the 25th International Symposium on the Autonomic Nervous System:

    KEY FINDING: 33% of POTS patients have organ-specific autoantibodies, suggesting an autoimmune basis for at least 1/3 of patients.

    CITATION: W. Singer, C.J. Klein, P.A. Low, V.A. Lennon. Autoantibodies in the postural tachycardia syndrome. Clinical Autonomic Research (2014): 24:199-243.

    Read more here:

  2. alex3619

    alex3619 Senior Member

    Logan, Queensland, Australia
    Yes, but with one caveat. Trace amounts of organ specific antibodies are not likely to be highly debilitating. Antibody titres will be important in a follow up study.

    However a number of these will affect neurological capacity, and we simply do not know enough to predict the result of even low levels. So nervous system targeting autoantibodies could be dangerous at even small levels.

See more popular forum discussions.

Share This Page